GL1X · GenesisL1 explorer

Research workbench

Active site thrombin inhibitors

Analyse Active site thrombin inhibitors in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1WAY
Type
protein
Length
290 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Thrombin light chain; Thrombin heavy chain; Hirugen
EC
3.4.21.5
UniProt
P00734
Ligands
L02
Pockets
2 · best druggability 0.57

Structure

x-ray diffraction · 3 distinct chains · 18% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AThrombin light chain (EC 3.4.21.5)protein2934% helix, 0% strandP00734
BThrombin heavy chain (EC 3.4.21.5)protein25116% helix, 35% strandP00734
IHirugenprotein1030% helix, 0% strand—

Ligands and binding sites

  • L02 · 4-[3-(4-chlorophenyl)-1H-pyrazol-5-yl]piperidine · ligand · chains B
  • DMS · Dimethyl sulfoxide · additive · 3 copies · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12600.570.7837L02, DMS
2690.330.7515empty

Interfaces

2 interfaces between chains.

  • A–B · 1159 Ų buried · 27 hydrogen bonds · protein-protein
  • B–I · 636 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide, 1 modified (disulfide, sulfation).

Compared structures

  • 1WAY · Active site thrombin inhibitors · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.